Zhifei Biotech: Report for the third quarter of 2024

SZSIOct 25 12:00 ET · Announcements

Chongqing Zhifei Biological Products (300122.SZ): Adjuvanted Quadrivalent Influenza Vaccine Approved for Clinical Trials.

chongqing zhifei biological products (300122.SZ) announced that it was developed by its wholly-owned subsidiary, anhui zhifei dragon horse biological pharmaceutical limited...

Zhitong FinanceOct 25 11:22 ET

Chongqing Zhifei Biological Products (300122.SZ): net income in the first three quarters was 2.151 billion yuan, a year-on-year decrease of 67.07%.

On October 25, Gelonhui reported on Chongqing Zhifei Biological Products (300122.SZ) third quarter report for 2024, with the company achieving revenue of 22.786 billion yuan in the first three quarters, a decrease of 41.98% year-on-year; net income attributable to shareholders of the listed company was 2.151 billion yuan, a decrease of 67.07% year-on-year; net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 2.143 billion yuan, a decrease of 66.41% year-on-year; basic earnings per share were 0.8976 yuan.

Gelonghui FinanceOct 25 08:17 ET

Express News | Zhifei Biological Products Says Q3 Net Loss at 83.7 Mln Yuan

ReutersOct 25 07:34 ET

These 4 Measures Indicate That Chongqing Zhifei Biological Products (SZSE:300122) Is Using Debt Reasonably Well

Simply Wall StOct 18 21:42 ET

chongqing zhifei biological products (300122.SZ): The application for production registration of freeze-dried human rabies vaccine (human diploid cells) has been accepted.

GeLonghui October 16th | Chongqing Zhifei Biological Products (300122.SZ) announced that the company recently received a report from its wholly-owned subsidiary Anhui Zhifei Longkema Biological Pharmaceutical Co., Ltd. (hereinafter referred to as “Zhifei Longkema”), stating that the application for production registration of the freeze-dried human rabies vaccine (human diploid cells) independently developed by Zhifei Longkema has been issued the “Acceptance Notice” (Acceptance No.: CXSS2400112) by the National Medical Products Administration. Rabies is an acute infectious disease caused by the rabies virus, clinically manifested as unique symptoms such as hydrophobia, aerophobia, pharyngeal muscle spasms, and progressive paralysis. Once symptoms appear, the disease

Gelonghui FinanceOct 16 06:49 ET